MAPK3 and pulmonary arterial hypertension: Therefore, we concluded that AS‐IV could increase the expression of CCN1 in the advanced state of PAH, activate ERK1/2 signalling pathway, reduce apoptosis caused by PAH and ameliorate PAH, which provides a theoretical basis for further study of protective effects of AS‐IV against PAH.